0000086312-26-000065
SEC filingThe Travelers Companies, Inc. (TRV) reported strong financial results for the fiscal year ended December 31, 2025, demonstrating robust operational performance. Total revenues reached $48.83 billion, driven primarily by $43.91 billion in premiums and $3.96 billion in net investment income. The company achieved a net income of $6.29 billion, resulting in a basic earnings per share of $28.00 and a diluted EPS of $27.00. Operational efficiency was highlighted by an income before income taxes of $7.80 billion. On the balance sheet, total assets stood at $143.71 billion against total liabilities of $110.81B, culminating in total shareholders’ equity of $32.89 billion. Cash generation remained solid, with net cash provided by operating activities totaling $10.61 billion. The company actively returned capital to shareholders, paying $979.0 million in dividends and repurchasing $3.00 billion in treasury stock. The firm maintains a strong liquidity position with $842.0 million in cash and $5.72 billion in short-term securities.
The Travelers Companies, Inc. delivered robust financial performance for the fiscal year ending December 31, 2025. The company reported total revenues of $48.83 billion, with premiums contributing the largest share at $43.91 billion, supplemented by net investment income of $3.96 billion. Income before income taxes totaled $7.80 billion, leading to a net income of $6.29 billion after accounting for $1.51 billion in income tax expense. This profitability translated to a basic earnings per share of $28.00 and a diluted EPS of $27.00. The weighted average basic shares outstanding were 224.2 million.
Total revenues of $48.83 billion were primarily driven by core insurance operations. Premiums constituted the dominant revenue stream at $43.91 billion. Net investment income contributed significantly at $3.96 billion, reflecting strong portfolio performance. Fee income added $495.0 million, while other revenues contributed $508.0 million. The company also recorded net realized investment losses of $48.0 million. Claims and claim adjustment expenses were $27.22 billion, representing the largest cost component against premium revenue.
The company demonstrated solid profitability metrics. The operating margin, calculated as income before income taxes divided by total revenues, stood at approximately 16.0%. Total claims and expenses amounted to $41.03 billion. Key expense components included claims and claim adjustment expenses of $27.22 billion, amortization of deferred acquisition costs of $7.27 billion, and general and administrative expenses of $6.12 billion. Interest expense was contained at $425.0 million. The effective tax rate was approximately 19.4%.
Net cash provided by operating activities was strong at $10.61 billion. The company utilized $7.65 billion in investing activities, primarily for purchases of fixed maturities ($18.77 billion) offset by maturities and sales. Financing activities used $2.66 billion, including $3.00 billion for share repurchases and $979.0 million in dividends paid, partially offset by $1.23 billion in debt issuance. Total assets were $143.71 billion, including total investments of $101.18 billion. Total liabilities were $110.81 billion, resulting in shareholders’ equity of $32.89 billion.
The document provided does not contain specific forward-looking guidance or strategic priorities from management. Investors should refer to the MD&A section of the full 10-K filing for detailed discussions on risk factors, market conditions, and future operational strategies. The company's strong capital position and cash generation provide a solid foundation for future operations.